Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

STS01 1% effectively promotes hair regrowth with minimal side effects.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

New gel formulas without ethanol and propylene glycol, containing a minoxidil-methyl-β-cyclodextrin complex, have been created for treating hair loss.

Bicalutamide may help treat female pattern hair loss.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Minoxidil caused a severe rash in a patient, which improved after stopping the drug.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

The emulgel with specific ingredients was effective for treating hair loss.

The FDA approved a new Pfizer drug for hair loss in teens.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

WYE-130600 may cause skin thickening and irritation.

The minoxidil gel could be a better treatment for hair loss than traditional forms.

Bicalutamide shows promise for treating female hair loss.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

ALRV5XR effectively promotes hair regrowth in both men and women through different mechanisms.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

The gel with apigenin and celery juice improved hair growth in rats without causing skin irritation.

Baricitinib shows promise in treating severe hair loss.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Adding Brij 78 to minoxidil microparticles in a certain solution helps them stick to the skin better and prevents clumping.

Erosive pustular dermatosis of the scalp can occur about 17 weeks after starting EGFR inhibitors, and early minocycline may help manage it.